BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35997709)

  • 1. Treatment of Polycystic Liver Disease: Impact on Patient-reported Symptom Severity and Health-related Quality of Life.
    Duijzer R; Barten TRM; Staring CB; Drenth JPH; Gevers TJG
    J Clin Gastroenterol; 2022 Oct; 56(9):731-739. PubMed ID: 35997709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.
    Abu-Wasel B; Walsh C; Keough V; Molinari M
    World J Gastroenterol; 2013 Sep; 19(35):5775-86. PubMed ID: 24124322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management.
    Cnossen WR; Drenth JP
    Orphanet J Rare Dis; 2014 May; 9():69. PubMed ID: 24886261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of polycystic liver disease. Update on the management.
    Aussilhou B; Dokmak S; Dondero F; Joly D; Durand F; Soubrane O; Belghiti J
    J Visc Surg; 2018 Dec; 155(6):471-481. PubMed ID: 30145049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on the pathophysiology and management of polycystic liver disease.
    Wong MY; McCaughan GW; Strasser SI
    Expert Rev Gastroenterol Hepatol; 2017 Jun; 11(6):569-581. PubMed ID: 28317394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the clinical application of the polycystic liver disease questionnaire: determination of a clinical threshold to select patients for therapy.
    Barten TRM; Staring CB; Hogan MC; Gevers TJG; Drenth JPH;
    HPB (Oxford); 2023 Aug; 25(8):890-897. PubMed ID: 37095030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Disease-Specific Questionnaire to Assess Patient-Reported Symptoms in Polycystic Liver Disease.
    Neijenhuis MK; Gevers TJ; Hogan MC; Kamath PS; Wijnands TF; van den Ouweland RC; Edwards ME; Sloan JA; Kievit W; Drenth JP
    Hepatology; 2016 Jul; 64(1):151-60. PubMed ID: 26970415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic Liver Disease: Advances in Understanding and Treatment.
    Masyuk TV; Masyuk AI; LaRusso NF
    Annu Rev Pathol; 2022 Jan; 17():251-269. PubMed ID: 34724412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of polycystic liver disease.
    Gevers TJ; Drenth JP
    Nat Rev Gastroenterol Hepatol; 2013 Feb; 10(2):101-8. PubMed ID: 23296249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MELD score exception for polycystic liver disease.
    Smira G; Matei E; Gheorghe L; Popescu I
    Chirurgia (Bucur); 2013; 108(3):418-21. PubMed ID: 23790796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Questionnaire PLD-complaint-specific assessment identifies need for therapy in polycystic liver disease: A multi-centric prospective study.
    Billiet A; Temmerman F; Coudyzer W; Van den Ende N; Colle I; Francque S; De Maeght S; Janssens F; Orlent H; Sprengers D; Delwaide J; Decock S; De Vloo C; Moreno C; van Malenstein H; van der Merwe S; Verbeek J; Nevens F
    United European Gastroenterol J; 2023 Sep; 11(7):633-641. PubMed ID: 37278135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation.
    Schnelldorfer T; Torres VE; Zakaria S; Rosen CB; Nagorney DM
    Ann Surg; 2009 Jul; 250(1):112-8. PubMed ID: 19561475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of percutaneous sclerotherapy and surgical treatment in patients with symptomatic simple liver cysts and polycystic liver disease.
    Erdogan D; van Delden OM; Rauws EA; Busch OR; Lameris JS; Gouma DJ; van Gulik TM
    World J Gastroenterol; 2007 Jun; 13(22):3095-100. PubMed ID: 17589926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Orthotopic liver transplantation in therapy of advanced polycystic liver disease].
    Klupp J; Bechstein WO; Lobeck H; Neuhaus P
    Chirurg; 1996 May; 67(5):515-21. PubMed ID: 8777881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial Embolization for Treatment of Symptomatic Polycystic Liver Disease: More than 2-year Follow-up.
    Zhang JL; Yuan K; Wang MQ; Yan JY; Xin HN; Wang Y; Liu FY; Bai YH; Wang ZJ; Duan F; Fu JX
    Chin Med J (Engl); 2017 Aug; 130(16):1938-1944. PubMed ID: 28776546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation for polycystic liver disease.
    Pirenne J; Aerts R; Yoong K; Gunson B; Koshiba T; Fourneau I; Mayer D; Buckels J; Mirza D; Roskams T; Elias E; Nevens F; Fevery J; McMaster P
    Liver Transpl; 2001 Mar; 7(3):238-45. PubMed ID: 11244166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after arterial embolization therapy in patients with polycystic kidney and liver disease.
    Hoshino J; Suwabe T; Hayami N; Sumida K; Mise K; Kawada M; Imafuku A; Hiramatsu R; Yamanouchi M; Hasegawa E; Sawa N; Takei R; Takaichi K; Ubara Y
    J Nephrol; 2015 Jun; 28(3):369-77. PubMed ID: 25230989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe polycystic liver diseases: hepatectomy or waiting for liver transplantation?: Two case reports.
    Zhang Z; Hu K; Yang J; Zhou Y; Wang Z; Huang Y
    Medicine (Baltimore); 2019 Dec; 98(49):e18176. PubMed ID: 31804334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of liver volume on polycystic liver disease-related symptoms and quality of life.
    Neijenhuis MK; Kievit W; Verheesen SM; D'Agnolo HM; Gevers TJ; Drenth JP
    United European Gastroenterol J; 2018 Feb; 6(1):81-88. PubMed ID: 29435317
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.